Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

NCT: NCT03706430 · TERMINATED

NCT IDNCT03706430
StatusTERMINATED
Start Date2018-09-24
Completion2021-10-20
SponsorMasimo Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, nonrandomized, sequential data collection study to evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including stroke volume variation (SVV) and/or pulse pressure variation (PPV).

Frequently Asked Questions

What is Validation of RPVi as a Parameter to Predict Fluid Responsiveness?

Validation of RPVi as a Parameter to Predict Fluid Responsiveness is a clinical trial registered under NCT03706430. Current status: TERMINATED.

What is the status of NCT03706430?

The current status of NCT03706430 (Validation of RPVi as a Parameter to Predict Fluid Responsiveness) is: TERMINATED.

When did Validation of RPVi as a Parameter to Predict Fluid Responsiveness start?

Validation of RPVi as a Parameter to Predict Fluid Responsiveness started on 2018-09-24.

Related Devices

K151644Masimo Root Vital Signs Monitoring System and AccessoriesMasimo Corporation K153225Masimo Root Monitoring System and AccessoriesMasimo Corporation K160526Masimo O3 Regional Oximeter SystemMasimo Corporation K160940Masimo Disposable Transflectance Forehead SensorMasimo Corporation K162603Masimo O3 Regional Oximeter SystemMasimo Corporation

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑